NCT06960395 2026-04-13
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Vir Biotechnology, Inc.
Phase 1 Recruiting
Clinical Trials
8 trialsNCT07207707 2026-03-13
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting
NCT06994806 2026-03-03
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting
NCT07363967 2026-01-23
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
Beijing StoneWise Technology Co., Ltd
Phase 1 Recruiting
NCT07128914 2025-12-19
A Clinical Study of GO306 in Patients With Advanced Solid Tumors
GeneSail Biotech (Shanghai) Co., Ltd.
Phase 1 Recruiting
NCT07174453 2025-12-08
Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies
University of Kansas Medical Center
Phase 3 Recruiting
NCT07264803 2025-12-04
PDTF
Qilu Hospital of Shandong University
Phase 2 Recruiting
NCT07071090 2025-07-23
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Heronova Pharmaceuticals
Phase 1 Recruiting